Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
LbuCas13a N3.2 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/03/2021 1 0
Valrubicin Potential treatment - theoretical effect Experimental Antiviral Feb/02/2021 1 0
Lianhua Qingwen Recommended by China's NHC Guidelines Natural product Other treatment Jan/29/2021 3 0
1-[1-(6-Chloroquinolin-4-yl)piperidin-4-yl]piperidin-3-ol Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021 1 0
Excel (.xslx) CSV (.csv)